Recruiting PHASE4 Erector Spinae Block

New treatment option for Erector Spinae Block

Official title Erector Spinae Block in Reducing Peri-operative Opioid Consumption in Total Abdominal Hystrectomy

ClinicalTrials.gov ID: NCT07178262

What this study is testing

What is Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)?

Erector Spinae (ESP) Block with Bupivacaine (Marcaine®) is an investigational medicine, being studied as a potential treatment for erector spinae block.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
Hystrectomy is a surgical procedure that involves removal of uterus from the body of patient using a lower abdominal incision. This is an extremely painful procedure which causes discomfort and greatly increases opioids consumption in the peri-operative period.
  • Phase 4: studies an already-approved treatment

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 16 to 80, women only. Healthy volunteers may be eligible.

You may be able to join if

  • American Society of Anesthesiologists (ASA) class: I, II and III .
  • Elective Hysterectomy under General Anesthesia.

You likely can't join if

  • Lack of consent
  • Body mass index \>35 kg/m2
  • Allergic to study medicine
  • Opioid abuse or misuse disorder
  • Chronic pain

The study team makes the final eligibility decision.

Where it's taking place

  • Islamabad, Federal, Pakistan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 16 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Islamabad, Federal, Pakistan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.